Articles from Antidepressants

Primary tabs

Head meds: The college student's comprehensive guide to antidepressants - Dailyuw

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 17:29

Head meds: The college student's comprehensive guide to antidepressants  DailyuwIn one scene in “Black Mirror: Bandersnatch,” a choose-your-own-adventure episode of the popular Netflix series, the protagonist has to choose between ...

What you need to know before quitting antidepressants - New York Post

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 16:40

What you need to know before quitting antidepressants  New York Post When Magie Serpica decided to go off the meds, following general guidelines for tapering, she was met with a litany of unpleasant symptoms, including nausea, ...

Can You Take CBD & Antidepressants? Here's What You Should Know - Bustle

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 16:33

Can You Take CBD & Antidepressants? Here's What You Should Know  BustleThere's no denying that CBD, aka cannabidiol, was the reigning trend of last year, and shows no signs of stopping. From edible products and tinctures, to bath ...

FDA Approves New Fast-Acting Ketamine-Derived Antidepressant Spray - IFLScience

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 16:02

FDA Approves New Fast-Acting Ketamine-Derived Antidepressant Spray  IFLScienceEsketamine is a derivative of the drug ketamine, and could provide fast-acting relief from depression.

Sharp regional variations in benzo prescribing - RTE.ie

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 15:40

Sharp regional variations in benzo prescribing  RTE.ieIn Prescription Nation, the three-part series from RTÉ Investigates, we look at prescription drug consumption in the public health system. In part two, we look at ...

Vertex CEO… Pharmalittle: Allergan depression drug fails three trials - STAT

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 14:29

Vertex CEO… Pharmalittle: Allergan depression drug fails three trials  STATAllergan disclosed an experimental depression drug failed to improve symptoms more than placebo when added to existing antidepressants in three studies.

Dark Money Group Has Run More Than $100000 Worth Of Facebook Ads Targeting High Drug Prices - Kaiser Health News

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 13:52

Dark Money Group Has Run More Than $100000 Worth Of Facebook Ads Targeting High Drug Prices  Kaiser Health NewsCitizens for Truth in Drug Pricing” has no website and appears to exist only as a collection of Facebook advertisements, but the spokesman is a well-known ...

Ketamine, the new anti-depressant, has been blowing minds for decades - Washington Post

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 13:25

Ketamine, the new anti-depressant, has been blowing minds for decades  Washington PostOnce used as a combat zone anesthetic, the psychedelic drug has a long strange history.

Amazon Dismantling Its Pop-Up Stores, Expanding Other Retail Concepts 03/07/2019 - MediaPost Communications

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 13:21

Amazon Dismantling Its Pop-Up Stores, Expanding Other Retail Concepts 03/07/2019  MediaPost CommunicationsIt's only natural that what pops up must come down. Why then, does it seem surprising that Amazon has decided to close all 87 of the Pop-Up kiosks it has ...

Allergan's Depression Candidate Fails in Studies, Stock Down - Zacks.com

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 12:50

Allergan's Depression Candidate Fails in Studies, Stock Down  Zacks.comAllergan's (AGN) three acute pivotal studies on depression candidate, rapastinel, fail to meet their primary endpoint. Stocks declines 1.9%

Pages